ArticleTranslational lung cancer research2024

Breaking barriers: patient-derived xenograft (PDX) models in lung cancer drug development-are we close to the finish line?

Nagla Abdel Karim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.